Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in North America, India, Japan, Europe, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides financing to real estate developers, as well as corporate clients in non-real estate sectors. It also offers housing loans to individual customers and is building a multi-product retail lending platform, as well as engages in investment activities. In addition, the company provides integrated drug discovery, development, and manufacturing services to pharmaceutical companies for drug substance and drug products; inhalation anaesthesia, injectable anaesthesia, pain management, intrathecal spasticity, and other products used in hospitals or other managed care settings; and over-the-counter products in various categories, including skincare, gastrointestinal care, women's intimate range, kid's wellbeing and baby care, pain management, oral, and respiratory healthcare. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India. The ISIN of this stock is INE140A01024.